[The antiestrogen effect]

Review OA: closed CC0
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-09-10 ⓘ

This review examines estradiol synthesis and action steps to evaluate various antiestrogenic compounds, including antigonadotropes and synthesis inhibitors, for their therapeutic potential in managing estrogen hyperactivity.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The effects of estradiol, which are requisite for the normal occurrence of events related to reproduction, are not restricted to that field. They play a part in the overall trophicity of the female organism. On the other hand, relative or absolute estrogen hyperactivity results in harmful clinical effects and in disastrous cellular consequences, i.e. initiation or promotion of genital carcinomas. After a review of the different steps of the synthesis and action of estradiol, the various compounds that are active on these steps are considered: antigonadotropes (norsteroid progestogens, androgens, danazol, prolactin, corticosteroids, LHRH), inhibitors of estrogen synthesis (aminogluthetimide and testolactone), compounds that increase catabolism (progestogens), and antagonists of the cellular effect of estradiol (tamoxifen, nafoxidin, clomifen, progesterone, progestogens and androgens). The putative or established site of action and the main aspects of therapeutic use are given for each substance.

My notes (saved in your browser only)

MeSH descriptors

Estrogen Antagonists Aminoglutethimide Aminoglutethimide Androgens Androgens Clomiphene Clomiphene Estrogen Antagonists Estrogen Antagonists Estrogens Estrogens Estrogens Female Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Humans Hydrocortisone Hydrocortisone Progestins Progestins

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-10T10:31:24.809595+00:00
pubmed
last seen: 2026-10-08T21:58:08.863946+00:00
License: CC0 · commercial use OK